Phenylketonuria Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 18thNovember 2014
Summary The industry analysis specialist, has released its new report, Phenylketonuria Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Phenylketonuria Therapeutics market. The report identifies the key trends shaping and driving the global Phenylketonuria Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Phenylketonuria Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-phenylketonuria-therapeutics-pipeline-assessment-and-marketforecasts-135251 Scope The report provides information on the key drivers and challenges of the Phenylketonuria Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Phenylketonuria Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Phenylketonuria Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Phenylketonuria Therapeutics market. - Analysis of key recent licensing and partnership agreements in Phenylketonuria Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Phenylketonuria Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Phenylketonuria Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Whats the next big thing in the global Phenylketonuria Therapeutics market landscape? Identify, understand and capitalize.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com
Table of Content 2 Phenylketonuria Therapeutics - Introduction 2.1 Overview 2.2 Epidemiology 2.3 Etiology 2.4 Signs and Symptoms 2.5 Diagnosis 2.6 Treatment 2.7 Management 2.8 Referral Pathway for Phenylketonuria 2.9 GlobalData Pipeline Report Guidance 3 Phenylketonuria Therapeutics - Market Characterization 3.1 Phenylketonuria Therapeutics Market Size (2007-2011) - Global Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
3.2 Phenylketonuria Therapeutics Market Forecast (2011-2019) - Global 3.3 Phenylketonuria Therapeutics Market Size (2007-2011) - The US 3.4 Phenylketonuria Therapeutics Market Forecast (2011-2019) - The US 3.5 Phenylketonuria Therapeutics Market Size (2008-2011) - The UK 3.6 Phenylketonuria Therapeutics Market Forecast (2011-2019) - The UK 3.7 Phenylketonuria Therapeutics Market Size (2008-2011) - France 3.8 Phenylketonuria Therapeutics Market Forecast (2011-2019) - France 3.9 Phenylketonuria Therapeutics Market Size (2008-2011) - Germany 3.10 Phenylketonuria Therapeutics Market Forecast (2011-2019) - Germany 3.11 Phenylketonuria Therapeutics Market Size (2008-2011) - Italy 3.12 Phenylketonuria Therapeutics Market Forecast (2011-2019) - Italy 3.13 Phenylketonuria Therapeutics Market Size (2008-2011) - Spain 3.14 Phenylketonuria Therapeutics Market Forecast (2011-2019) - Spain 3.15 Phenylketonuria Therapeutics Market Size (2008-2011) - Japan 3.16 Phenylketonuria Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Phenylketonuria Therapeutics Market 3.17.1 Drivers for the Phenylketonuria Therapeutics Market 3.17.2 Barriers for the Phenylketonuria Therapeutics Market 3.18 Key Events Impacting the Future Market 3.19 Opportunity and Unmet Need 3.19.1 Opportunity and Unmet Need for the Phenylketonuria Therapeutics Market 3.20 Key Takeaway 4 Phenylketonuria Therapeutics Market - Competitive Assessment 4.1 Overview 4.1.1 Strategic Competitive Assessment 4.2 Product Profiles of the Marketed Products in the Phenylketonuria Market 4.2.1 Kuvan (sapropterin dihydrochloride) 4.3 Key Takeaway 5 Phenylketonuria Therapeutics Market - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.2.1 Phenylketonuria Therapeutics - Phase II Pipeline 5.3 Phenylketonuria Pipeline by Mechanism of Action 5.4 Phenylketonuria Technology Trends Analytical Framework 5.5 Phenylketonuria Therapeutics - Drugs under Clinical Development 5.6 Profile of Drugs under Clinical Development 5.6.1 PEG-PAL 5.7 Key Takeaway 6 Phenylketonuria Therapeutics - Clinical Trials Mapping Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
6.1 Clinical Trials Mapping by Country (The US, EU5 and Japan) 6.2 Clinical Trials Mapping by Phase 6.3 Clinical Trials Mapping by Trial Status 6.4 Clinical Trials Mapping by Overall Sponsors 6.5 Clinical Trial Mapping by Prominent Sponsors 6.6 Top Companies Participating in Phenylketonuria Therapeutics Clinical Trials 7 Phenylketonuria Therapeutics - Strategic Assessment 7.1 Future Market Competition Scenario 7.2 Key Takeaway 8 Global Phenylketonuria Therapeutics - Future Players in The Market 8.1 Introduction 8.2 Company Profile 8.2.1 BioMarin Pharmaceuticals Inc. 9 Phenylketonuria Therapeutics - Licensing and Partnership Deals 10 Phenylketonuria Therapeutics - Appendix 10.1 Acronyms 10.2 Bibliography 10.3 Research Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Primary Research 10.3.4 Forecasting 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer List Of Tables Table 1: Biochemical Basis for Phenylketonuria Table 2: Historical Prevalence for Phenylketonuria for Seven Major Markets, 2006-2011 Table 3: Forecasted Prevalence for Phenylketonuria for Seven Major Markets, 2011-2019 Table 4: Characteristics of Therapeutics for BH4 responsive phenylketonuria patients Table 5: Phenylketonuria Therapeutics Market, Seven Major Markets, Revenue ($m), 2007-2011 Table 6: Phenylketonuria Therapeutics Market, Seven Major Markets, Market Forecast ($m), 2011-2019 Table 7: Phenylketonuria Therapeutics Market, The US, Revenue ($m), 2007-2011 Table 8: Phenylketonuria Therapeutics Market, The US, Market Forecast ($m), 2011-2019 Table 9: Phenylketonuria Therapeutics Market, The UK, Revenue ($m), 2008-2011 Table 10: Phenylketonuria Therapeutics Market, The UK, Market Forecast ($m), 2011-2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 11: Phenylketonuria Therapeutics Market, France, Revenue ($m), 2008-2011 Table 12: Phenylketonuria Therapeutics Market, France, Market Forecast ($m), 2011-2019 Table 13: Phenylketonuria Therapeutics Market,Germany, Revenue ($m), 2008-2011 Table 14: Phenylketonuria Therapeutics Market, Germany, Market Forecast ($m), 2011-2019 Table 15: Phenylketonuria Therapeutics Market, Italy, Revenue ($m), 2008-2011 Table 16: Phenylketonuria Therapeutics Market, Italy, Market Forecast ($m), 2011-2019 Table 17: Phenylketonuria Therapeutics Market, Spain, Revenue ($m), 2008-2011 Table 18: Phenylketonuria Therapeutics Market, Spain, Market Forecast ($m), 2011-2019 Table 19: Phenylketonuria Therapeutics Market, Japan, Revenue ($m), 2008-2011 Table 20: Phenylketonuria Therapeutics Market, Japan, Market Forecast ($m), 2011-2019 Table 21: Phenylketonuria - Phase II Pipeline Table 22: Phenylketonuria Therapeutics - Promising Drugs Under Clinical Development, 2012 Table 23: Phenylketonuria Therapeutics - Clinical Trials by Country, 2012 Table 24: Phenylketonuria Therapeutics - Clinical Trials by Phase, 2012 Table 25: Phenylketonuria Therapeutics - Clinical Trials by Status, 2012 Table 26: Phenylketonuria Therapeutics - Clinical Trials by Overall Sponsors, 2012 Table 27: Phenylketonuria Therapeutics - Clinical trials by Prominent Sponsors, 2012 Table 28: Phenylketonuria Therapeutics - Clinical Trials by Top Companies Participating in Therapeutics Clinical Trials, 2012 Table 29: Phenylketonuria Therapeutics, Clinical Pipeline by Company, 2012 Table 30: BioMarin Pharmaceuticals Inc. - Promising Molecules in the Pipeline for Phenylketonuria, 2012 Table 31: PhenylketonuriaTherapeutics, Global, Deals ($m), 2012 List Of Figures Figure 1: Factors Modulating Phenylketonuria Figure 2: Patient Share of Phenylketonuria in the Seven Major Markets, 2011 Figure 3: Mechanism of Formation of Phenylketonuria Figure 4: The Basic Structure of the Human PAH Gene Figure 5: Allelic Mutations Associated with Phenylketonuria Figure 6: Treatment Algorithm for Phenylketonuria Figure 7: Referral Pathway for Phenylketonuria Figure 8: Phenylketonuria Therapeutics Market, Seven Major Markets, Revenue ($m), 20072011 Figure 9: Phenylketonuria Therapeutics Market, Market Shares (%), 2011 Figure 10: Phenylketonuria Therapeutics Market, Seven Major Markets, Forecast ($m), 20112019 Figure 11: Phenylketonuria Therapeutics, Market Share (%), 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 12: Phenylketonuria Therapeutics Market, The US, Revenue ($m), 2007-2011 Figure 13: Phenylketonuria Therapeutics Market, The US, Market Forecast ($m), 2011-2019 Figure 14: Phenylketonuria Therapeutics Market, The UK, Revenue ($m), 2008-2011 Figure 15: Phenylketonuria Therapeutics Market, The UK, Market Forecast ($m), 2011-2019 Figure 16: Phenylketonuria Therapeutics Market, France, Revenue ($m), 2008-2011 Figure 17: Phenylketonuria Therapeutics Market, France, Market Forecast ($m), 2011-2019 Figure 18: Phenylketonuria Therapeutics Market, Germany, Revenue ($m), 2008-2011 Figure 19: Phenylketonuria Therapeutics Market, Germany, Market Forecast ($m), 2011-2019 Figure 20: Phenylketonuria Therapeutics Market, Italy, Revenue ($m), 2008-2011 Figure 21: Phenylketonuria Therapeutics Market, Italy, Market Forecast ($m), 2011-2019 Figure 22: Phenylketonuria Therapeutics Market, Spain, Revenue ($m), 2008-2011 Figure 23: Phenylketonuria Therapeutics Market, Spain, Market Forecast ($m), 2011-2019 Figure 24: Phenylketonuria Therapeutics Market, Japan, Revenue ($m), 2008-2011 Figure 25: Phenylketonuria Therapeutics Market, Japan, Market Forecast ($m), 2011-2019 Figure 26: Phenylketonuria Therapeutics, Key Events Impacting Future Market, 2012 Figure 27: Opportunity and Unmet Need in the Phenylketonuria Therapeutics Market, 2012 Figure 28: Phenylketonuria Market - Strategic Competitor Assessment, 2012 Figure 29: Mechanism of Action of Kuvan Figure 30: Technology Trends Analytical Framework of the Phenylketonuria Pipeline Description, 2012 Figure 31: Phenylketonuria Therapeutics - Clinical Trials by Country, 2012 Figure 32: Phenylketonuria Therapeutics - Clinical Trials by Phase, 2012 Figure 33: Phenylketonuria Therapeutics - Clinical Trials by Status, 2012 Figure 34: Phenylketonuria Therapeutics - Clinical Trials by Overall Sponsors, 2012 Figure 35: Phenylketonuria Therapeutics - Clinical Trials by Prominent Sponsors, 2012 Figure 36: Phenylketonuria Therapeutics Clinical Trials - Company Sponsors by Phase, 2012 Figure 37: Phenylketonuria Therapeutics, Strategic Assessment, 2012 Figure 38: GlobalData market Forecasting Model, 2012
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Enterprise Wide Licence
$ 11985
Related Reports: Ankylosing Spondylitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Graves Disease Therapeutics - Pipeline Assessment and Market Forecast to 2019 Supraventricular Tachycardia (SVT) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hunter Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Phenylketonuria Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-phenylketonuriatherapeutics-pipeline-assessment-and-market-forecasts-135251 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/